Community-acquired, antibiotic-unassociated Clostridium difficile colitis: Report of four patients

Infectious Diseases in Clinical Practice

Volumn 6, Issue 6, 1997, Pages 385-390

  Esposito, Anthony L ^a,b   Agraharkar, Mahendra L ^b   Pitts, Wilfred G ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b SAINT VINCENT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

AGED; ARTICLE; CASE REPORT; CLOSTRIDIUM DIFFICILE; COLITIS; DIARRHEA; FEMALE; HOSPITALIZATION; HUMAN; MALE; MEDICAL RECORD; TEACHING HOSPITAL;

EID: 0030817754     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019048-199706060-00007     Document Type: Article

References (29)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 1978; 289:531-4.
2. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
3. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990;162:678-84.
4. Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridiiim difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990; 11:283-90.
5. Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis 1995;20(2 Suppl):S263-S265.
6. Hirschhorn LR, Trnka Y, Onderdonk A, Lee MLT, Platt R. Epidemiology of community-acquired Clostridiiim difficile-associated diarrhea. J Infect Dis 1994;169:127-33.
7. Wald A, Mendelow H, Bartlett JG. Non-antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. Ann Intern Med 1980;92:798-9.
8. Moskovitz M, Bartlett JG. Recurrent pseudomembranous colitis unassociated with prior antibiotic therapy. Arch Intern Med 1981;141:663-4.
9. Peikin SR, Galdibini J, Bartlett JG. Role of Clostridiiim difficile in a case of non-antibiotic-associated pseudomembranous colitis. Gastroenterology 1980;79:948-51.
10. Kelly CP, Pothoulakis C, LaMont JT. Clostridiiim difficile colitis. N Engl J Med 1994;10:330:257-62.
11. Fekety R, Kim KH, Brown D, et al. Epidemiology of antibiotic-associated colitis: isolation of Clostridiiim difficile from the hospital environment. Am J Med 1981;70: 906-8.
12. Gerding DN, Olson MM, Peterson LR, et al. Clostridiiim difficile-associated diarrhea and colitis. A prospective case-controlled epidemiologic study. Arch Intern Med 1986;146:95-100.
13. George WL, Rolfe RD, Mulligan ME, Finegold SM. Infectious diseases 1979-antimicrobial agent-induced colitis: an update. J Infect Dis 1979;140:266-8.
14. Thomas DR, Bennett RG, Laughon BE, Greenough WB III, Bartlett JG. Postantibiotic colonization with Clostridium difficile in nursing home patients. J Am Geriatr Soc 1990;38:415-20.
15. Aronsson B, Mollby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. J Infect Dis 1985; 151:476-84.
16. Borriello SP, Honour P, Turner T, Barclay F. Household pets as a potential reservoir for Clostridium difficile infection. J Clin Pathol 1983:36:84-7.
17. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981; 143:42-9.
18. Gurian L, Ward TT, Katon RM. Possible foodborne transmission in a case of pseudomembranous colitis due to Clostridium difficile. Gastroenterology 1982;83:465-9.
19. Oishi JS, Mulligan ME, Finegold SM. Failure to detect Clostridium difficile in foods. J Infect Dis 1983;148:360.
20. Tumbarello M, Tacconelli E, Leone F, Cauda R, Ortona L. Clostridium difficile-associated diarrhea in patients with human immunodeficiency virus infection: a case-control study. Eur J Gastroenterol Hepatol 1995:7:259-63.
21. Katz DA, Lynch ME, Littenberg D. Clinical prediction to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med 1996;100:487-95.
22. Cudmore MA, Silva J Jr, Fekety R, Liepman MK, Kim KH. Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med 1982;142:333-5.
23. Trnka YM, LaMont JT. Association of Clostridhim difficile toxin with symptomatic relapse of chronic inflammatory bowel disease. Gastroenterology 1981;80:693-6.
24. Silva J, Fekety R, Werk C, et al. Inciting and etiolgic agents of colitis. Rev Infect Dis 1984;6(1 Suppl):S214-S21.
25. Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridhim difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol 1991;12:345-8.
26. Morris JG Jr, Jarvis WR, Nunez-Montiel OL, et al. Clostridium difficile. Colonization and toxin production in a cohort of patients with malignant hematologie disorders. Arch Intern Med 1984;l44:967-9.
27. Miller RR, Jick H. Antibiotic-associated colitis. Clin Pharmacol Ther 1977;22:l-6.
28. Rubin MS, Bodenstein LE, Kent C. Severe Clostridhim difficile colitis. Dis Colon Rectum 1995;38:350-4.
29. Samore MH, Bettin KM, DeGirolami PC, et al. Wide diversity of Clostridhim difficile types at a tertiary referral hospital. J Infect Dis 1994;170:615-21.